Thermo Fisher Scientific Inc (TMO)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	5,995,000	5,941,000	4,200,000	4,503,000	3,188,000	3,270,000	5,198,000	5,362,000	5,191,000	6,031,000	6,062,000	5,390,000	6,375,000	6,912,000	5,739,000	5,702,000	5,729,000	5,618,000	5,567,000	5,200,000
Total assets	US$ in thousands	98,726,000	97,057,000	94,105,000	94,658,000	97,154,000	90,536,000	90,579,000	92,747,000	95,123,000	73,600,000	67,698,000	65,931,000	69,052,000	64,061,000	61,593,000	58,688,000	58,381,000	56,729,000	57,970,000	55,596,000
ROA		6.07%	6.12%	4.46%	4.76%	3.28%	3.61%	5.74%	5.78%	5.46%	8.19%	8.95%	8.18%	9.23%	10.79%	9.32%	9.72%	9.81%	9.90%	9.60%	9.35%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $5,995,000K ÷ $98,726,000K
= 6.07%

Thermo Fisher Scientific Inc.'s return on assets (ROA) has exhibited a decreasing trend in the most recent quarters, dropping from 6.36% in Q1 2023 to 6.07% in Q4 2023. This indicates a decline in the company's ability to generate profits from its assets during this period. Furthermore, compared to the same quarter in the previous year, ROA has decreased significantly, with a notable drop from 7.15% in Q4 2022 to 6.07% in Q4 2023. This decline suggests potential inefficiencies in asset utilization or a decrease in profitability relative to the company's asset base. It is essential for stakeholders to monitor this trend closely to assess the company's financial performance and efficiency in deploying its assets effectively.